Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.

Saved in:
Bibliographic Details
Title: Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.
Authors: Pauken KE; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA., Shahid O; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Lagattuta KA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Harvard-MIT Medical Scientist Training Program, Harvard Medical School, Boston, MA., Mahuron KM; Department of Surgery, University of California, San Francisco, San Francisco, CA., Luber JM; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Biomedical Informatics, Harvard Medical School, Boston, MA., Lowe MM; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Huang L; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard H. Chan School of Public Health, Boston, MA., Delaney C; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Long JM; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.; Department of Bioengineering, Northeastern University, Boston, MA., Fung ME; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Newcomer K; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Tsai KK; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Chow M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Guinn S; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA., Kuchroo JR; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA., Burke KP; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA., Schenkel JM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Rosenblum MD; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Daud AI; Department of Medicine, University of California, San Francisco, San Francisco, CA., Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Singer M; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.
Source: The Journal of experimental medicine [J Exp Med] 2021 Apr 05; Vol. 218 (4).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20200920